This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Yong Ho Huh: Innovator in Drug Carrier Technology
Introduction
Yong Ho Huh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on IgG4 Fc fragments. With a total of 5 patents, Huh's inventions are paving the way for advancements in therapeutic applications.
Latest Patents
Huh's latest patents focus on the development of modified IgG4 Fc fragments that serve as drug carriers. One of his notable inventions is a modified IgG4 Fc fragment that minimizes the effector functions of the IgG4 Fc and reduces chain exchange with in vivo IgG. This innovation maintains the in vivo activity of the drug conjugate while improving its duration in the body. Another patent also relates to a modified IgG4 Fc fragment, emphasizing its utility as a drug carrier when combined with various drugs.
Career Highlights
Throughout his career, Yong Ho Huh has worked with reputable companies such as Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug delivery systems and contribute to significant advancements in the field.
Collaborations
Huh has collaborated with notable colleagues, including Sung Youb Jung and Se Chang Kwon. These partnerships have fostered a collaborative environment that enhances innovation and research in drug carrier technologies.
Conclusion
Yong Ho Huh's contributions to the field of drug delivery through his innovative patents highlight his role as a leading inventor. His work continues to influence the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
